Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma

A small subset of patients with nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHLs) develop a non-Hodgkin lymphoma either concurrently or subsequently, usually T-cell/histiocyte-rich B-cell lymphomas (T/HRBCL), which are subtypes of diffuse large B-cell lymphomas (DLBCL). The standard tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyung-Chul, Jung, Sung-Hoon, Ahn, Jae-Sook, Kim, Mi-Young, Yang, Deok-Hwan, Kim, Yeo-Kyeoung, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: August, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433022/
https://www.ncbi.nlm.nih.gov/pubmed/22949903
http://dx.doi.org/10.1159/000341562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433022/
https://www.ncbi.nlm.nih.gov/pubmed/22949903
http://dx.doi.org/10.1159/000341562

Ejemplares similares